ASCO-contributor/ Clinical/ Market Access/ Oncology/ Partner content/ Partner Content/ Partner Content/ Pharma Market Access/ Press releases Positive PIII results for VYXEOS revealed at ASCO Madelyn Hanson & Stephanie Hawthorne AML, asco, cancer, kantar health, leukemia, Oncology, pharma, VYXEOS 0 Comment Building on the announcement made in March of this year, Celator Pharmaceuticals has today (June 4th) presented the Share X Positive PIII results for VYXEOS revealed at ASCO https://pharmaphorum.com/partner-content-oncology/positive-piii-results-for-vyxeos-revealed-at-asco/
ASCO-contributor/ Healthcare/ Market Access/ Oncology/ Partner Content/ Partner Content/ Partner content/ Press releases What are the key presentations at ASCO 2016? Kantar Health asco, cancer, kantar, Oncology, pharma 0 Comment The 2016 American Society of Clinical Oncology (ASCO) annual meeting starts today (3rd June), and it promises to Share X What are the key presentations at ASCO 2016? https://pharmaphorum.com/partner-content-oncology/what-are-the-key-presentations-at-asco-2016/
AML, asco, cancer, kantar health, leukemia, Oncology, pharma, VYXEOS
0 Comment
